The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pearls & Myths: Experts Offer Advice & Dispel Myths

Pearls & Myths: Experts Offer Advice & Dispel Myths

February 25, 2020 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Pearl: Churg-Strauss granulomas (cutaneous extravascular necrotizing granuloma)—typically on the elbows—are a common cutaneous manifestation of GPA. “You have to examine patients for these,” Dr. Stone said. “They don’t hurt. Patients will not notice them. But they’re a key clue to the possibility of GPA.”

You Might Also Like
  • Five Coding and Billing Myths that Can Hurt Your Practice
  • What Makes a Master Clinician? Dr. Sterling West Talks about His Career & Offers Advice for Future Rheumatologists
  • Experts Offer Management Tips, from Contracts to Credentials to Audits
Explore This Issue
March 2020
Also By This Author
  • A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden

Myth: Cyclophosphamide is more powerful than rituximab for treating GPA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pearl: “Methotrexate is a crummy treatment for vasculitis. The same goes for azathioprine and MMF [mycophenolate mofetil],” Dr. Stone said. “We have much better drugs now—and safer drugs. These old [treatments] that don’t work very well should be put out to pasture.”

Pearl: In IgG4-related disease, hypocomplementemia implies renal involvement. “We don’t fully understand why that is the case,” Dr. Stone said, “but it really correlates well with renal disease.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Myth: Weight loss occurs in patients with IgG4-related disease because of overwhelming systemic inflammation. “That’s not why the weight drops off these patients,” Dr. Stone said. “It drops off these patients because they have pancreatic disease—exocrine pancreatic failure.”

More Pearls
During the session, Sterling West, MD, professor of medicine at the University of Colorado School of Medicine, offered additional advice.

Sterling West, MD

His first rule for every case is to look for symptom causes other than a connective tissue disease. “First, ask yourself, could these symptoms be due to an adverse drug effect? Could it be due to an infection, cancer or a clot? There are some other things, but these four are particularly important, because all of them are treated differently than increased immunosuppression,” he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Consider sleep apnea and abuse in fibromyalgia. “You’re going to see people who have particularly severe fibromyalgia. And one of the things that has impressed us is the number of people who have sleep apnea as the cause,” Dr. West said. “We ask them, do they snore? … The other element we see is a history of sexual or physical abuse, particularly in childhood or teenage years.”

With gout, consider energy drinks. “Rule out energy drinks [as a cause], particularly for younger individuals that come in with gout,” he said. “Energy drinks have a lot of fructose in them. Fructose is broken down into ATP [adenosine triphosphate]—that’s what gives you your energy—and ATP is broken down into uric acid.”

Dr. West noted seronegative rheumatoid arthritis (RA) candidates may have calcium pyrophosphate dihydrate crystal deposition disease (CPPD) or pseudogout. “They may never have had an attack that sounds like pseudogout,” he said.

Pages: 1 2 3 | Single Page

Filed Under: 2019 ACR/ARP Annual Meeting, Career Development, Professional Topics Tagged With: 2019 ACR/ARP Annual Meeting, Career, rheumatology, tipsIssue: March 2020

You Might Also Like:
  • Five Coding and Billing Myths that Can Hurt Your Practice
  • What Makes a Master Clinician? Dr. Sterling West Talks about His Career & Offers Advice for Future Rheumatologists
  • Experts Offer Management Tips, from Contracts to Credentials to Audits
  • Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.